Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

17. Juli 2018 07:30 ET | Quelle: Innovation Pharmaceuticals, Inc.

Innovation Pharmaceuticals Signs Drug Product Manufacturing Contract with CoreRx to Formulate and Package Brilacidin for Oral Mucositis in Sachet Form

BEVERLY, Mass., July 17, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has signed a...
10. Juli 2018 09:41 ET | Quelle: Medtronic plc

First-Year Results from Medtronic and UnitedHealthcare Value-Based Relationship Demonstrate Cost-Savings and Reduced Hospital Admissions

First-Year Results Demonstrate a 27 Percent Decline in Rate of Preventable Hospital Admissions for Medtronic Insulin Pump Users Compared to Patients on Multiple Daily Injections of Insulin ...
10. Juli 2018 09:00 ET | Quelle: School Specialty, Inc

School Specialty and Mobilize Rescue Systems Collaborate to Improve Student Safety through The 21st Century Safe School Initiative

GREENVILLE, Wis. and ROCHESTER, N.Y., July 10, 2018 (GLOBE NEWSWIRE) -- School Specialty, Inc. (OTCQB:SCOO) and Mobilize Rescue Systems announced today a partnership to place life-saving medical...
10. Juli 2018 07:00 ET | Quelle: Gopher Protocol, Inc.

Gopher Concluded Phase One of Avant! AI

Moves into Phase Two - Semantic Segmentation Machine Learning System Development SAN DIEGO, CA, July 10, 2018 (GLOBE NEWSWIRE) -- Gopher Protocol Inc. (OTCQB:GOPH) ("Gopher"), a company...
29. Juni 2018 10:00 ET | Quelle: Innovation Pharmaceuticals, Inc.

Innovation Pharmaceuticals Announces Database Lock for Phase 2b Trial of Oral Prurisol for Psoriasis

BEVERLY, Mass., June 29, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces database lock for its Phase 2b...
28. Juni 2018 16:30 ET | Quelle: Innovation Pharmaceuticals, Inc.

Innovation Pharmaceuticals Announces $7 million Milestone Funding Agreement with Aspire Capital

BEVERLY, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announced that it has entered into...
28. Juni 2018 11:36 ET | Quelle: Medtronic plc

Medtronic Launches the MiniMed(TM) 670G System Performance Guarantee for Payers and Employers

DUBLIN- June 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of the MiniMed(TM) 670G Performance Guarantee Program - an outcomes-based...
25. Juni 2018 07:00 ET | Quelle: Medtronic plc

Medtronic Receives CE Mark for MiniMed(TM) 670G Hybrid Closed Loop System

DUBLIN - June 25, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité Européenne) Mark for the MiniMed(TM) 670G hybrid closed...
24. Juni 2018 19:48 ET | Quelle: Medtronic plc

MiniMed 670G System Real-World Data Show Improved Time in Range and Reduced Lows and Highs Across All Patient Groups Including a 41 Percent Time in Range Improvement for Previous MDI Patients

DUBLIN - June 24, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 32,178 users of the MiniMed(TM) 670G system. Data on...
22. Juni 2018 18:15 ET | Quelle: Medtronic plc

Artificial Intelligence-Powered Sugar.IQ(TM) Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available

Real-World Experience Data on Sugar.IQ App Use Presented at the 78th Scientific Sessions of the American Diabetes Association DUBLIN AND CAMBRIDGE - June 22, 2018 - Medtronic plc (NYSE:MDT), the...

Vorherige Seite

Nächste Seite